Pliant Therapeutics Provides Corporate Update and Reports Second Quarter 2026 Financial Results

Go back to Pliant Therapeutics Provides Corporate Update and Reports Second Quarter 2026 Financial Results
(NASDAQ: PLRX) Delayed: 0.89 --0 (-0%)
Previous Close $0.89    52 Week High $ 
Open $0.89    52 Week Low $ 
Day High $0.89    P/E N/A 
Day Low $0.89    EPS $ 
Volume 4,830